EUVIMEDEUVIMED entdecken
Crossref

Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease

Yingzhi Zhang, Leilei Zhao, Xiaowen Yu, Huayan Liu, Min Zhao

Biosensors and Bioelectronics · 2026-04 · 298 · 118399

DOI: 10.1016/j.bios.2026.118399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-04. Verfasst von Yingzhi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyan…. Hauptthemen laut MEDLINE: Alzheimer Disease, Flow Cytometry, Extracellular Vesicles, Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Liaoning Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a kind of progressive neurodegenerative disorder caused by neuron damage, which imposed significant economic and social burdens. Early and precise AD diagnosis remains an obstacle in the clinic, primarily attributable to the absence of simple, noninvasive, and reliable detection methods. Extracellular vesicles (EVs) carry molecular cargos reflecting cellular origin and can cross the blood-brain barrier, serving as promising biomarkers for neurological diseases. Herein, we propose a novel EV-CATCH-based nano-flow cytometry strategy for rapid, noninvasive, and single-vesicle profiling of multiple AD-related protein biomarkers on EVs. The EV-CATCH enables controlled capture and on-demand release of serum EVs, ensuring high specificity and structural integrity of the isolated vesicles. Four core AD biomarkers on serum EVs were profiled at the individual vesicle level for stratification, and their clinical utility was assessed in two cohorts. The first cohort included 29 Aβ-PET-negative and 42 Aβ-PET-positive participants. In this group, the biomarker panel demonstrated an AUC of 0.873 in differentiating Aβ-PET status, further supporting its value in reflecting cerebral amyloid pathology. The second cohort consisted of 110 serum samples, comprising those from healthy controls as well as from subjects with mild cognitive impairment (MCI) and AD. Combined analysis of the four EV-associated biomarkers yielded high diagnostic accuracy, with areas under the receiver operating characteristic curves (AUCs) of 0.932 for MCI and 0.923 for AD. This clinically accessible single-vesicle method enables multiplexed and sensitive EV profiling for early AD diagnosis, accurate disease stratification and longitudinal monitoring, facilitating timely intervention thus promoting better patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseFlow CytometryExtracellular VesiclesBiosensing TechniquesHumansBiomarkersFemaleMaleAgedCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer's diseaseEV-CATCHExtracellular vesiclesNano-flow cytometrySingle-vesicle profiling

Substanzen

Biomarkers

Autor:innen und Institutionen

  • National Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, 110001, PR China.
  • Department of Neurology, The First Hospital of China Medical University, Shenyang, 110001, PR China. Electronic address: liuhuayancmu@163.com.
  • National Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, 110001, PR China. Electronic address: minzhao@cmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Department of Education of Liaoning Province
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, Y., Zhao, L., Yu, X., Liu, H., & Zhao, M. (2026). Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease. Biosensors and Bioelectronics, 298, 118399. https://doi.org/10.1016/j.bios.2026.118399

Vancouver

Zhang Y, Zhao L, Yu X, Liu H, Zhao M. Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease. Biosensors and Bioelectronics. 2026;298:118399. doi:10.1016/j.bios.2026.118399

BibTeX
@article{Zhang2026,
  author = {Zhang, Yingzhi and Zhao, Leilei and Yu, Xiaowen and Liu, Huayan and Zhao, Min},
  title = {Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {298},
  pages = {118399},
  doi = {10.1016/j.bios.2026.118399}
}
Kostenlos starten →